The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
112726498 11272649 8 F 20140506 20160822 20150715 20160829 PER PHHY2014US072268 NOVARTIS 43.99 YR F Y 0.00000 20160829 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
112726498 11272649 1 PS GILENYA FINGOLIMOD HYDROCHLORIDE 1 Oral UNK UNK, QD 22527 CAPSULE QD
112726498 11272649 2 C LYRICA PREGABALIN 1 Unknown U 0
112726498 11272649 3 C PROMETHEGAN PROMETHAZINE HYDROCHLORIDE 1 Unknown UNK U 0
112726498 11272649 4 C PREDNISONE. PREDNISONE 1 Unknown UNK Y 0
112726498 11272649 5 C MARIJUANA CANNABIS SATIVA SUBSP. INDICA TOP 1 Unknown U 0
112726498 11272649 6 C MARIJUANA CANNABIS SATIVA SUBSP. INDICA TOP 1 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
112726498 11272649 1 Multiple sclerosis
112726498 11272649 2 Pain
112726498 11272649 3 Product used for unknown indication
112726498 11272649 4 Product used for unknown indication
112726498 11272649 5 Muscle spasticity
112726498 11272649 6 Restless legs syndrome

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
112726498 11272649 Acne
112726498 11272649 Alanine aminotransferase increased
112726498 11272649 Aspartate aminotransferase increased
112726498 11272649 Blood alkaline phosphatase increased
112726498 11272649 Blood creatinine decreased
112726498 11272649 Candida infection
112726498 11272649 Dermatitis
112726498 11272649 Fatigue
112726498 11272649 Fungal skin infection
112726498 11272649 Gait disturbance
112726498 11272649 Gastroenteritis
112726498 11272649 Headache
112726498 11272649 Herpes zoster
112726498 11272649 Hyperreflexia
112726498 11272649 Hypoaesthesia
112726498 11272649 Intervertebral disc protrusion
112726498 11272649 Laceration
112726498 11272649 Liver function test increased
112726498 11272649 Lymphocyte count decreased
112726498 11272649 Migraine
112726498 11272649 Multiple sclerosis relapse
112726498 11272649 Muscular weakness
112726498 11272649 Nausea
112726498 11272649 Oedema peripheral
112726498 11272649 Pain in extremity
112726498 11272649 Paraesthesia
112726498 11272649 Rash
112726498 11272649 Sleep apnoea syndrome
112726498 11272649 Tooth infection
112726498 11272649 Upper respiratory tract infection
112726498 11272649 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
112726498 11272649 1 20140506 0
112726498 11272649 2 20140801 0
112726498 11272649 3 20141231 0
112726498 11272649 4 20150520 20150528 0
112726498 11272649 5 20140915 0